Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that insurance coverage for cranial hair prostheses in patients with alopecia areata is generally inadequate, adding to their financial and psychological burdens.

This review discusses the current limitations in insurance coverage and access to facial masculinization surgery in the US and suggests that expanding insurance policies may help reduce care inequities.

This study observed that insurance coverage for oral tofacitinib in alopecia areata patients was difficult to obtain, with 71% of patients ultimately not receiving approval despite the drug's efficacy as an off-label treatment.

This study found that health insurance mandates following the Affordable Care Act increased colorectal cancer screening rates by 2.8 percentage points among U.S. adults aged 50 to 74.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

This review covers the ongoing debate on measuring underinsurance in health coverage and reports no new empirical results, recommending a national effort to standardize underinsurance metrics.

This cross-sectional study examined gender-affirming surgeries in Canada, finding significant variation in provincial insurance coverage, with Prince Edward Island covering the most procedures and Nunavut the least, while noting a general lack of in-province procedures in the territories.

In this study, researchers found that 48.59% of dermatologists in Ontario do not accept OHIP referrals for hair loss, with average wait times of about 4.5 months for those who do; this raises accessibility concerns.

This study found that there is a low prevalence and wide variability in U.S. insurance coverage for ancillary gender surgeries, with specific criteria often required for favorable coverage.

This review identifies significant variability in insurance coverage for gender-affirming surgeries in the US, affecting equitable access to care for transgender individuals and suggesting a need for health policy reforms.

This study analyzed the cost-effectiveness of scalp cooling as a means of preventing chemotherapy-induced hair loss and found it to be financially reasonable compared to dermatologic management strategies, suggesting that it should be considered for routine insurance coverage due to its cost-effectiveness.

This study found that, among COVID-19 patients in South Korea, hypertension, diabetes, and other comorbidities significantly increased mortality risk, with the age-adjusted Charlson comorbidity index being a strong predictor of death.

In this study, a case of a 70-year-old woman with central centrifugal cicatricial alopecia showed that using a high-quality hair prosthesis improved her quality of life and mood, as measured by PHQ-9 and Skindex-29 scores, though such wigs are rarely covered by insurance.

This study found that an age-adjusted Charlson comorbidity index of four or more strongly predicts mortality in South Korean COVID-19 patients, highlighting the impact of comorbidity burden and older age on disease severity.

This study observed that patients with alopecia areata often have comorbidities and experience significant healthcare costs, with treatments like systemic therapies being infrequently used.

The study reported that from 2016 to 2020, the number of patients with alopecia areata in Taiwan increased, with severe cases utilizing more systemic therapies and having higher outpatient visits than mild/moderate cases.

This cross-sectional survey study found that stigmatizing attitudes toward people with alopecia are present in various social and professional settings, with stigma levels varying by alopecia severity and perceptions of its medical nature.

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

This article narrates a case where a patient with androgenetic alopecia faced high out-of-pocket costs for finasteride 1 mg and sought to reduce expenses by requesting a prescription for 5 mg tablets typically used for BPH, which are covered by insurance.

This article discusses the regulation of the aesthetics sector, highlighting political and regulatory challenges, and reports no new research findings.

This review highlights that alopecia areata significantly impacts mental health and finances, with patients facing depression, anxiety, and substantial out-of-pocket expenses due to limited insurance coverage.

This study highlights significant psychosocial distress and access barriers faced by South Asian patients, suggesting improved provider education, broader insurance coverage, and enhanced patient assistance programs as necessary steps to achieve equitable healthcare access.

This study found that spironolactone was not independently associated with increased breast cancer recurrence and may be considered for treating alopecia in survivors.

This editorial emphasizes the critical need for laser protection supervisors in the aesthetic sector due to a rise in laser-related claims attributed to inadequate training and safety protocol adherence, highlighting that better understanding and supervision can help mitigate risks.

This study found that patients with alopecia areata had an increased risk of mortality from self-harm, psychiatric diseases, and lung cancer compared to the general population.

This review highlights the inconsistent and often insufficient global coverage of cranial prostheses for medical hair loss, with variations depending on healthcare system models and a general lack of standardized recognition as medically necessary devices.

This case report describes instances of lipedematous scalp and lipedematous alopecia in white adults, indicating these rare conditions may be more widespread and frequent in this population than previously thought.

This study reports increased instances of trichotillomania-related hair loss in young girls during the COVID-19 pandemic, which may be linked to social isolation and school closures.

This case study reports instances of hair loss in two patients taking sertraline, suggesting that even low doses of SSRIs might cause this rare side effect, which could impact treatment adherence.